SIMCERE PHARMACEUTICAL GROUP Accumulated Other Comprehensive Income
SIMCERE PHARMACEUTICAL GROUP had Accumulated Other Comprehensive Income of -CNY 104.15 million as of 2012-12-31, per its 20-F filed 2013-04-26.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2013-04-26
- 2012-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -104.15M CNY.
- 2011-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -104.61M CNY.
- 2010-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -97.51M CNY.
CNY
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2012-12-31 | -104.15M CNY 20-F · filed 2013-04-26 |
| 2011-12-31 | -104.61M CNY 20-F · filed 2013-04-26 |
| 2010-12-31 | -97.51M CNY 20-F · filed 2012-04-25 |
USD
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2012-12-31 | -$16.72M 20-F · filed 2013-04-26 |